Introduction
Page 5 line 2: The authors mention that cellular processes involved in the exchange of GPI-APs (including TNTs) "could" be involved in spreading aggregated proteins. Here they cite different papers showing TNTs implication in viral transmission and surprisingly do not mention that it has been recently published that cells "do" spread prions (specifically mouse PrPc and PrPSc) this way (via TNTs) (Gousset et al, 2009, Gousset and Zurzolo 2009) . (see also page 20 of the discussion when they talk about the implication of transfer of prions by oral infection. TNTs have been shown to spread moPrPSc and infection from cells of the immune system (DCs) to different models of prion replicating cells including neurons) Page 5 line 23: authors do not show data relative to "other protein" but Sup35 Page 6 line 19: the citation of Krammer et al is biased and used just to support the absence of Hsp104 activity in mammalian cells while they should discuss and explain the differences between their data and the paper of Krammer (see below).
Page 6 and 7 and throughout the whole paper: It is assumed that GPI anchorage is conferring the properties of transmission throughout the paper while the GPI anchor could be relevant also for other feature of the disease and/or other factors other that the GPI anchor could be involved in prion spreading. Furthermore they use an unanchored (wildtype) Sup35 as a control for this hypothesis. Besides the fact that (again) they should directly confront their results with the ones from Krammer, it is possible that the membrane anchorage alone (and not the GPI) could have a role in the transfer. The correct control would be to express Sup35 with a transmembrane domain. Furthermore, different TM domains that anchor the protein in cholesterol/sphingolipid-enriched domains versus fluid membrane would provide more information considering the importance of the membrane microenvironment on the observed phenomenon. Figures   Fig. 1 : description of plasmids used and immunofluorescence to show that Sup35-GFP-GPI has the expected distribution that one would expect from a GPI-anchored protein (PM and Golgi), similar to GFP-GPI in N2a cells. Immunofluorescence using Sup35 N Ab (without permeabilisation showed that Sup35-GFP-GPI is expressed on the surface of the cells). However because there is a high GFP signal inside the cells, indirect immunofluorescence in permeabilized cells should be also performed to show that all Sup35 is also GFP positive. Indeed if the GFP is cleaved this would compromise all their results, in particular the newly formed aggregates in Fig : They looked at the effects of adding recombinant amyloid fibrils labeled with Alexa-568 to cells expressing Sup35-GFP-GPI. For control they show cells treated with PBS, Ure2p80 (recombinant fibrils from the prion domain residues 1-80 in yeast). It is not clear why they do not show GFP-GPI transfected cells + Sup35NM but claim that the binding was minimal (as quantitated in 2C). They should show an example of these pictures, which would be more relevant compared to the PBS control. In addition the pictures shown are of poor quality and low resolution makes it impossible to distinguish between up-taken (inside the cells) and surface bound proteins. They should show and use better images for quantification (see general comment on image acquisition below). It is not clear why using the same approach, Krammer et al. show that NM35 aggregates can be uptaken by N2a cells (both wt and transfected with cytosolic Sup35). Here they should comment and explain the striking differences in findings. Furthermore kinetics of binding and internalization of Sup35 should be performed to uncouple its ability to bind the cells from its capability to induce aggregation of Sup35 GFP GPI. Besides considering Krammer's data, these findings are quite surprising considering that PrP expression was shown to be irrelevant for mammalian prion endocytosis. In addition neuronal cells should be able to bind and internalize different kind of aggregates (like also previously shown by the same authors Magalhaes et al. 2005) . In the text the authors talk about 23 passages referring to this figure while in the legend it is max 16 passages. Page 10, section 2, 2nd sentence: Another contradiction of the authors' contention that Sup35 should not interact with other proteins. This time the authors state that the fusion of mCherry to Sup35-GPI causes persistent aggregates whereas the GFP fusion protein is induced to form aggregates only upon addition of mis-conformed Sup35. This indicates that proteins from evolutionary distant organisms can interact with Sup35 to the extent that they change its aggregation properties.
At this point in the paper, the authors claim to have obtained the "Characterization of selfpropagating Sup35-GF-GPI aggregates induced by Sup35NM fibrils". While in fact no characterization has been done. They simply have shown that the two bind to each other and that it eventually results in the propagation of Sup35-GPI aggregate. They do not show how the binding occurs or any mechanisms for aggregation and/or propagation. Fig. 4 : It is quite difficult to fully understand this figure just by reading the text. Page 10-11 : The authors speak of "cell surface sheet-like accumulations". It is unclear and far from proven that these accumulations are 1) on the cell surface or 2) equivalent to these aggregates detected in the filter-trap assay (given that they are not observed by microscopy in the mCherrySup35-GPI expressing cells but that aggregates on the filter-trap assay are observed in lysates derived from these cells (Fig 4B) ) 4A and B: It is not clear if Sup35-mCGPI aggregation is induced by fibrils or if it is able to aggregate by itself. In this last case some explanation should be provided about the reasons why mC but not GFP Sup35 GPI forms aggregates independently of induction. The authors should quantify the percentage of GFP aggregates that colocalize with Sup35mCGPI. 4C: I do not understand the meaning of the first four samples of the graph. If they represent pure cultures I don't see how the authors can define "recipient" cells and why when mcherry expressing cells are used the % of recipient cells is not 100%. Does it mean that Sup35MCGPI aggregates can just be transferred to Sup35-GFP-GPI? An important control should be to co-culture Sup35mCGPI with wt cells or cells expressing the other construct to really evaluate the capability of the same aggregates to spread between cells. The differences reported in their co-culture could be due to the fact that they are comparing the spreading of mCherry protein in very different aggregation states. These experiments would also lead them to discriminate between the roles of the GPI anchor, expressed by the donor and/or the recipient cells, in the spreading and in the propagation processes. It is quite surprising that during "aggregate fragmentation" occurring in such intimate intercellular contact and exerting a seeding activity SupGFP GPI cells are able to incorporate SupMCGPI aggregates but SupMCGPI do not retain any GFP signal. The opposite seems to occur when fixed SupmCGPI cells are used. Some possible explanation should be provided. It would be also interesting to determine by colocalization with appropriate markers if the new aggregates are really formed on the PM or intracellularly. Also it would be important to know if the SupmCGPI aggregates are intracellular and if contact with SupGFPGPI could eventually trigger their PM redistribution. During seeding I would expect GFP signal to increase even independently of the MCGPI signal especially after mCherry aggregates are not sheared anymore.
In addition aggregation of SupGFPGPI should be distinguish from its simple recruitment to the SupmCGPI aggregates if the authors want to prove they are really looking at induction of aggregation. For example they could perform biochemical assays on sorted cells after 3 days of coculture (if the 1% of cells that show transfer does not constitute a limiting factor...). 4D: The authors speak of aggregate shearing and fragmentation. This cannot be assessed by microscopic evidence. Since they admit as much on introducing these terms on page 12 ("It is difficult to determine if this represented shearing of a single large aggregate versus subdivision of a cluster of smaller aggregates"). Here, there is no attempt at any type of quantification. The author claim that they observed aggregation leading to fragmentation and that it can happens via cell-cell contact or via filopodia/TNTs. How often does aggregation between cells lead to fragmentation into both cells? Into one cell? What is the frequency of direct cell-cell contact compare to TNT-like structures? (see comment on live imaging) At this point the authors state that the data indicate that "aggregation can occur through direct cellcell interactions" ...data allow to "visualize fundamental processes important for the in vivo propagation and spreading..."
What the author forgot to mention is that very little of this information is new. Indeed, the authors failed to acknowledge the fact that these results agree with what was previously shown by Kanu et al (2002) while studying mouse prion. Indeed, it has been shown that cell-cell contact is necessary and more efficient for prion propagation. Furthermore in a more recent paper, Gousset et al (2009) have also shown that cell contact was necessary for the spreading of scrapie infection and they showed that TNTs could efficiently be used by GFP-PrP and PrPSc.
Overall, the only new data is the visualization of the aggregation and splitting of the aggregates between the two cells in contact. However, the data are not clear cut (see below comment on live imaging) as the authors admit, and therefore this phenomenon would need to be better analyze and would require some quantification to determine the relevance of these potentially important observations. Kanu et al. 2002) show that GPI aggregates were visible in these co-cultures (not with Sup35GFP-GPI or mC-GPI) and that after 6 passages, aggregates were barely visible.
The author conclude that these "observations established that fixed Sup35-mC-GPI aggregates efficiently induced acute but not persistent Sup35-GFP-GPI aggregation". It is difficult to understand how a few observations without any quantification can "establish" any conclusions. These data "suggest" acute aggregation but clearly some type of quantification will be necessary to validate the observations. They should also explain why fixation is inducing green auto-fluorescence and most importantly how they distinguish between auto-fluorescence and the specific signal coming from GFP. These data show that the presence of GPI anchored Sup proteins, both in the donor and the recipient cells, is not sufficient to induce transfer despite de novo aggregate formation (or recruitment of SupGFPGPI see comments above). To better understand the exact role of the GPI in these processes, the authors could perform co-culture between fixed Sup GFP-GPI cells and live SupmCGPI (and maybe other combinations of the cell lines they produced) and verify if active transfer can occur in these conditions. It would be also very informative to determine if the initial seeding is required for active transfer.
The authors do show in Fig. 5C that Sup35-GFP-GPI can be added on top of other Sup35-GFP-GPI aggregates. While this is a very interesting observation, the lack of quantification, once more, preclude the reader from determining the relevance of such events. Fig 6: Here, the authors look at the effects of removing the GPI anchor from Sup35-GFP-GPI (Sup35NM construct, which behaves similar to the anchorless PrPC described previously by Chesebro et al., 2005) . After 2 days of treatment with Sup35NM-AF568, they see little evidence for GFP aggregation with the anchorless Sup35NM compared to the GPI-form.
The authors suggest that the anchor is therefore necessary for the self-propagating aggregation. Again, no quantification was available. Once again to separate spreading from capability to induce aggregation, the authors should try to transfect aggregate positive SupCGPI cell with SupGFP and look at aggregation of SupGFP. The GPI could be important for the active transfer of seeding aggregates to recipient cells but not for induction of aggregation itself.
Throughout the paper, the pictures acquired by wide field microscopy were not properly acquired and displayed, which explains the overall poor quality. In the Supplementary materials and methods the authors state that they took the pictures for Figs 2, 3 and 6 with a 10X objective and then used 4X digital magnification. I do not understand the rational behind this at all. As a general rule, digital magnification should be avoided at all cost. The authors should have used a higher objective instead of digital magnification, which lead to pixelation and degrade the image quality. A 10X objective is not the right objective to correctly describe and analyze specific events such as the one described in this paper. A 10X objective might be necessary in cases where the entire wells/coverslips need to be observed and further analyzed and quantified. In this case, any representative pictures should still be acquired with a higher objective to improve the image quality. Therefore, I would recommend that along with more quantification of the events observed, the authors should provide better pictures acquired with a higher objective and without digital magnification. We agree that the effects may not be specific to a GPI anchor-directed mode of membrane association. We have modified the Introduction and Results to better indicate this point. However, we do feel it is important to note that there are no natural examples of ordered aggregation of an intact transmembrane protein associated with a protein misfolding disorder. This is an interesting mechanistic question now raised by our current study. It is also the reason it was important to focus on the role of GPI anchor-directed membrane association in this first report.
2) The Discussion is quite lengthy, and while interesting, may benefit from some shortening. We have modified the Discussion to decrease the length by 1 page (from 15017 characters to 13536 characters).
Reviewer #2
Minor comments: a) In Fig 4B, line 4 should (I think) be Sup35-GFP without the GPI superscript. This label is actually correct as written. It refers to a "co-culture" of Sup35-GFP GPI cells with themselves as a control to show that Sup35-GFP GPI aggregates did not arise spontaneously. The label on the figure has been modified to clarify this point.
b) The authors should be aware that the filament-cleaving activity of Hsp104 reported by Shorter and Lindquist has not been reproduced in at least four other labs that have attempted it.
We apologize for this oversight. We will remove the reference to the Shorter and Lindquist paper.
c) The discussion seems overly long and wanders from the main points. We have modified the Discussion to decrease the length by 1 page (from 15017 characters to 13536 characters).
Reviewer #3 1. However, in an elegant study Krammer and co-authors (PNAS, Jan 2009) We respectfully disagree with this statement. While Krammer and colleagues were able to show that cytosolic Sup35 could be induced to aggregate by addition of exogenous rSup35 fibrils, they did not show that these newly-induced aggregates could transfer horizontally between unrelated cells as would be required for a protein aggregate to behave as a bona fide TSE prion in mammals. This is especially important for TSE prions as in vivo they must spread horizontally between unrelated cells of the same type and even between different cell types. We devoted significant space to discussing this distinction in our manuscript. Furthermore, evidence to date suggests TSE prion replication is not a cytoplasmic process but rather involves propagation of PrP aggregates either on the cell surface and/or in endocytic trafficking compartments. The study by Krammer et al. reports the aggregation of a cytosolic protein induced by exogenous aggregates and vertical propagation (i.e. from mother to daughter cells) of the induced aggregates and as such is more related to the subject of propagation of yeast prions than TSE prions. In our view, the Krammer et al. study argues the possible existence of a yeast Hsp104-like activity in the mammalian cytosol but is less pertinent to the key elements associated with TSE prion propagation. We specifically commented on the limitations of the Krammer et al. paper (e.g. see Introduction, p. 6; Discussion, 20 We have modified the Discussion to decrease the length by 1 page (from 15017 characters to 13536 characters). We are not certain what aspects of the Discussion the reviewer considers "far-fetched" as every concept we propose is supported by citations to observations reported in the literature. We hope to have removed some of these "far-fetched" ideas in the course of shortening our Discussion. The reviewer frequently makes reference to "quantifications" without always specifying what exactly they wish to have quantified and how this impacts the conclusions of the study. In fact, we do provide quantification of aggregate binding (e.g. Fig. 2C, Fig. S6 ), protein transfer (Fig. 4C) , and number of replicates of our experiments so we do not fully understand the basis for this criticism. We have added quantification of other aspects of the study to the revised manuscript. (Gousset et al, 2009, Gousset and Zurzolo 2009 We share the reviewer's point of view that it will be interesting to investigate the effect of transmembrane anchoring on Sup35 aggregation. We already had plans to conduct these studies as our results raise this intriguing question. However, we completely disagree that these experiments should be included in the current manuscript. Our manuscript investigates the role of GPI anchoring in modulating protein aggregation and spread. In the Introduction, we outlined the rationale for beginning our studies with this form of membrane anchoring, particularly since this is the type of anchoring associated with the lone naturally transmissible protein misfolding disease. Therefore, it is the most biologically relevant to explore whether membrane anchoring accounts for the enhanced transmissibility of PrP prions vs. other protein misfolding disorders. We view investigation of other types of membrane anchoring as an important but completely separate mechanistic question -is it membrane-anchoring per se or specifically GPI anchoring that is required to support aggregate propagation and spread. To fully develop and characterize transmembrane-anchored forms of Sup35 and conduct full comparisons with GPI-anchored forms will be a paper unto itself. We make no claim that GPI anchoring is the sole mode of membrane association that can support aggregate propagation. We have modified the text in the Introduction, Results, and Discussion to more explicitly acknowledge that other forms of membrane anchoring could be important. Please see our response to point #1 regarding the comparison with the work of Krammer et al. Fig. 1 Fig 2B. The distribution we observed for GFP fluorescence in Sup35-GFP GPI cells is comparable to that reported by many studies in the literature for a variety of GPI-anchored proteins including PrP C with and without a GFP tag (e.g. Lee et al., J. Neurochem., 2001) . The N domain forms the core of Sup35 fibrils and constitutes the minimal prion-forming domain in yeast. Anti-Sup35N immunoblots show no evidence of abundant truncated Sup35N-positive fragments (Fig. 3B) . To relieve any remaining concerns we have added immunofluorescence data of permeabilized cells showing co-localization of anti-Sup35N immunoreactivity with GFP comparable to that observed when performing the immunolabeling with anti-GFP antibody (Fig. 1B) .
Title

Figures
Fig. 2: They looked at the effects of adding recombinant amyloid fibrils labeled with Alexa-568 to cells expressing Sup35-GFP-GPI. For control they show cells treated with PBS, Ure2p80 (recombinant fibrils from the prion domain residues 1-80 in yeast). It is not clear why they do not show GFP-GPI transfected cells + Sup35NM but claim that the binding was minimal (as quantitated in 2C). They should show an example of these pictures, which would be more relevant compared to the PBS control. In addition the pictures shown are of poor quality and low resolution makes it impossible to distinguish between up-taken (inside the cells) and surface bound proteins. They should show and use better images for quantification (see general comment on image acquisition below).
The GFP GPI + Sup35AF568 data were added at a late stage of manuscript preparation and images were excluded because of space considerations. We have now added the corresponding images. The PBS treated cells serve as a mock-treated control to establish that Sup35-GFP GPI aggregate induction required treatment with Sup35NM fibrils. These widefield fluorescence images are not intended to determine the subcellular localization of the aggregates. They are intended to demonstrate two things: 1) that punctate GFP accumulations appeared in only the Sup35NM fibril treated cells and 2) that there appeared to be greater and more frequent association of Sup35NM fibrils than Ure2p fibrils with the cells suggesting, but not proving, a specific Sup35-GPI dependent binding was taking place. We did not claim to interpret the subcellular localization of the Sup35NM-AF568 fibrils based on these images. This is now explicitly stated in the text to alleviate the potential for confusion on this issue.
As for the quality of the images, a 10x objective was used for technical purposes: it allowed the quantitation of a greater number of cells per image field. The quality of the 10x images without digital zoom may be assessed by looking at Figure S3 where one can see good quality images of Sup35 fibril treated cells showing a wide area with cells exhibiting punctate GFP accumulations. We thought these images would be more informative since they show reviewers the largest field of view possible. For the purposes of this section we felt the widefield images were sufficient for our purposes. In Figures 2 and 6 we now provide corresponding images of even better quality that were acquired with a 40x objective.
It is not clear why using the same approach, Krammer et al. show that NM35 aggregates can be up-taken by N2a cells (both wt and transfected with cytosolic Sup35). Here they should comment and explain the striking differences in findings.
Please see above (point #9). We carefully chose our wording to avoid implying any interpretation about the subcellular localization of the rSup35NM fibrils. Our point is that there appeared to be a high frequency of rSup35AF568 fibrils associated with Sup35-GFP GPI cells suggesting there is a specific interaction. We agree that proving a binding interaction is occurring in situ would require more advanced analysis.
We would also note that Krammer et al. themselves did not discuss their highly unusual observation that an unknown quantity (the percentage of input aggregates bound/internalized by the cells was not quantified) of the extracellular Sup35NM protein aggregates in their system can somehow gain access to the cytoplasm. The differences might be due to the use of different epitope tags or application of different doses of aggregates on the cells. Unfortunately, Krammer et al. do not provide sufficient information about the incubation conditions and fibril dose used in their study to make comparisons with our work.
Furthermore kinetics of binding and internalization of Sup35 should be performed to uncouple its ability to bind the cells from its capability to induce aggregation of Sup35 GFP GPI. Besides considering Krammer's data, these findings are quite surprising considering that PrP expression was shown to be irrelevant for mammalian prion endocytosis. In addition neuronal cells should be able to bind and internalize different kind of aggregates (like also previously shown by the same authors Magalhaes et al. 2005).
Please see point #9 above. We make no claims regarding the ability of the cells take up other aggregates. Fig 2C is only intended to show that there is apparently a greater frequency of Sup35NM-AF568 associating with the Sup35-GPI cells suggesting a specific interaction under our experimental conditions. As shown in Fig. 2B -C, we did observe low levels of Ure2p fibril association with the cells as might be predicted by other studies such as Magalhaes et al.
Fig. 3: Characterization of the Sup35-GPI aggregation induced by Sup35NM fibrils. In the text the authors talk about 23 passages referring to this figure while in the legend it is max 16 passages.
This was an oversight. We have analyzed Sup35 fibril treated cells out to at least 23 passages but this data is not shown. We have corrected this point in the text. Moreover, we also now show in the revised manuscript images of fibril-induced aggregate-positive Sup35-GFP GPI cells at 39 passages after fibril treatment (Fig. S4 ).
Page 10, section 2, 2nd sentence: Another contradiction of the authors' contention that Sup35 should not interact with other proteins. This time the authors state that the fusion of mCherry to Sup35-GPI causes persistent aggregates whereas the GFP fusion protein is induced to form aggregates only upon addition of mis-conformed Sup35. This indicates that proteins from evolutionary distant organisms can interact with Sup35 to the extent that they change its aggregation properties.
We regret that the reviewer has unfortunately misinterpreted our statement. In its original context, we stated (p.6): "It [Sup35NM] has no mammalian orthologs and would not be expected to participate in physiological interactions between mammalian amyloidogenic proteins and other molecules. This allows us to specifically assess the effects of GPI-anchoring and explore questions of broad interest such as whether GPI-anchored membrane-bound aggregates are directly neurotoxic."
This was a reference to potential intermolecular interactions of Sup35NM with endogenous mammalian proteins. Any protein may possess inherent properties that allow it to interact with other proteins in unpredictable, non-physiological ways. The reviewer's interpretation rather implies that there is some direct interaction between Sup35NM and mCherry, but there is no evidence from any of our experiments that this is the case (e.g. co-culture of cells expressing high levels of GPI-anchored mCherry or secreted anchorless Sup35NM-mCherry did not induce aggregation of Sup35-GFP GPI in separate cells). We did observe that aggregated Sup35-mCherry GPI arose spontaneously and through single-cell cloning we created a cell line producing these aggregates at high levels. This is not surprising as spontaneous aggregation can occur for all types of amyloidogenic proteins in rare cases and under the right conditions. Also, there are anecdotal reports among cell biologists who have used the mCherry protein for fusions to membrane-bound proteins that such proteins can form oligomers despite the fact that mCherry is monomeric when in solution (Shaner et al., Nat. Biotechnol., 2004) . Unfortunately, to our knowledge these observations have not been published or are only mentioned in passing (e.g. Piston and Rizzo, 2008 ). This might not be surprising given mCherry ultimately originated from DsRed, a tetrameric fluorescent protein (Shaner et al., Nat. Biotechnol., 2004) . It is beyond the scope of our study to fully address this issue as it is likely quite dependent on the context in which mCherry is expressed. In any case, according to our assays aggregation of GPI-anchored mCherry is dependent upon the Sup35NM domain. Sup35-mCherry GPI aggregates are biochemically indistinguishable from recombinant Sup35NM fibril-induced Sup35-GFP GPI aggregates. Most importantly for the purposes of our study, this includes their ability to seed self-propagating Sup35 aggregation. It may be that GPI-anchored mCherry has a natural tendency to interact with itself to form small oligomeric species not detected in our assays that can facilitate the spontaneous nucleation of the associated Sup35NM moieties by bringing them into close proximity. We have added information to the Results section to better explain these issues.
At this point in the paper, the authors claim to have obtained the "Characterization of selfpropagating Sup35-GF-GPI aggregates induced by Sup35NM fibrils". While in fact no characterization has been done. They simply have shown that the two bind to each other and that it eventually results in the propagation of Sup35-GPI aggregate. They do not show how the binding occurs or any mechanisms for aggregation and/or propagation.
This comment appears to arise from a different interpretation of the section title than we intended. We have shown that the induction of aggregation is specific to adding Sup35 fibrils in our system and we have shown data that the aggregates propagate efficiently for at least 39 passages (Fig. S4) . This section characterizes the biochemical properties of the induced, self-propagating Sup35-GFP GPI aggregates in three ways: 1) demonstrating the protein is aggregated by detergent insolubility assays with a non-denaturing detergent (sarkosyl); 2) showing the aggregates are highly stable by their resistance to solubilization with a high concentration of a strongly denaturing detergent (SDS); and 3) providing evidence that aggregation is associated with a conformational change in the N domain (as expected for Sup35NM polymers) through chymotrypsin resistance assays. These are all routine biochemical assays used previously to characterize Sup35 aggregates produced in yeast or generated in vitro from recombinant Sup35. To alleviate confusion, we have changed the section title to "Biochemical characterization of self-propagating Sup35-GFP GPI aggregates induced by Sup35NM fibrils".
Fig. 4: It is quite difficult to fully understand this figure just by reading the text. Page 10-11 : The authors speak of "cell surface sheet-like accumulations". It is unclear and far from proven that these accumulations are 1) on the cell surface or 2) equivalent to these aggregates detected in the filter-trap assay (given that they are not observed by microscopy in the mCherrySup35-GPI expressing cells but that aggregates on the filter-trap assay are observed in lysates derived from these cells (Fig 4B)) 4A and B: It is not clear if Sup35-mCGPI aggregation is induced by fibrils or if it is able to aggregate by itself. In this last case some explanation should be provided about the reasons why mC but not GFP Sup35 GPI forms aggregates independently of induction. The authors should quantify the percentage of GFP aggregates that colocalize with Sup35mCGPI.
We apologize that the reviewer could not understand the figure from reading only the text. We have tried to modify the text and figure legend to better explain the data. We do not agree with the reviewer's claims regarding the cell surface localization of the Sup35-mCherry GPI aggregates. Our analysis of confocal microscopy serial sections of data such as that shown in Fig. 4 and Fig. 5 as well as 3D volume rendering of the data (see Video 2) strongly suggests Sup35-mCherry GPI and newly-induced Sup35-GFP GPI aggregates are on the cell surface. Further evidence to argue the cell surface localization of Sup35-mCherry GPI aggregates includes: 1) our live-cell timelapse imaging data does not reveal any overt redistribution of mCherry fluorescence in Sup35-mCherry GPI cells before, during, or after contact of Sup35-mCherry GPI cells with Sup35-GFP GPI cells when the rapid GFP aggregate induction occurs; 2) in every case of new GFP aggregate formation in co-cultures of live Sup35-GFP GPI cells with fixed Sup35-mCherry GPI cells (where subcellular redistribution of Sup35-mCherry GPI is impossible), the intense punctate cell-surface accumulations of Sup35-mCherry GPI that we refer to as aggregates always co-localize with newly-induced Sup35-GFP GPI aggregates; and 3) the presence of what we observe as cell surface aggregates by microscopy shows a 100% correlation with the detection of detergent-insoluble, protease-resistant GPI-anchored Sup35, strongly arguing these deposits correspond to aggregated, conformationally-misfolded Sup35-GPI polymers. Finally, we now show unequivocal proof of the cell surface localization of Sup35-mC GPI aggregates and fibril-induced aggregates in Sup35-GFP GPI cells by cell surface immunolabeling (Fig. S4) . We do not understand the reviewer's comment that the aggregates are "not observed by microscopy in the mCherry-Sup35-GPI cells" when we have labeled the Sup35-mCherry GPI aggregates with arrows or arrowheads in Fig. 4, Fig. 5 , and Videos 1-4. Since there are no techniques available to readily determine whether some small fraction of the intracellular mCherry fluorescence corresponds to aggregated Sup35-mCherry GPI , we have inserted a comment to acknowledge this point in the Results section.
We added an estimate of the percentage of GFP aggregates that co-localize with Sup35-mCherry GPI . For other issues raises by the reviewer in this item, please see point #13.
4C: I do not understand the meaning of the first four samples of the graph. If they represent pure cultures I don't see how the authors can define "recipient" cells and why when mcherry expressing cells are used the % of recipient cells is not 100%. Does it mean that Sup35MCGPI aggregates can just be transferred to Sup35-GFP-GPI?
We apologize for the confusion on this graph. The flow cytometry was performed to detect mCherry transferred to recipient Sup35-GFP GPI expressing cells. The first four samples indicate that, in the gated region of the dot plot, there are no GFP+/mCherry+ cells detected in the samples when cultured alone. These data help establish that there is no background in the gated region contributed by any of the cells used in the co-cultures when cultured alone. The y-axis was determined by dividing the number of events found in the gated GFP+/mCherry+ by the total number of GFP+ (recipient cells) events counted in the co-culture. We have adjusted the label on the graph and the figure legend to clarify this issue.
17 The purpose of the data in Fig. 4C was to simply provide some quantitation of our observations made by confocal microscopy where: 1) there appeared to be a greater frequency of Sup35-mC GPI associated with Sup35-GFP GPI cells than mC GPI or Sup35-mC in the various co-cultures and 2) transfer appeared to have occurred from both Sup35-mC GPI cells and mC GPI to Sup35-GFP GPI cells. This is despite the fact that the Sup35-mC culture supernatants contain much higher levels of mCherry-tagged protein than either Sup35-mC GPI or mC GPI culture supernatants (Fig. S5 ). The FACS experiment in Fig. 4C verified these observations. Our conclusions from this experiment were that the data suggested that GPI-anchoring and the Sup35NM domains contribute to the intercellular transfer. The experiments proposed by the reviewer, although interesting, delve into questions that are tangential to our key point that it is specifically the GPI-anchored proteins that are transferred. Even if the aggregation state of Sup35-mC GPI affected the transfer efficiency, it would not undermine any of our conclusions as stated in this manuscript since the Sup35NM domains are required for Sup35-mC GPI aggregation.
The latter part of this comment appears to be mixing the results described in Fig. 5 with those of Fig.  4 . The events associated with induction and spread of GPI-anchored Sup35 aggregates in our system are complex. We never claimed that Sup35-mC GPI cells cannot acquire Sup35-GFP GPI protein in live cell co-cultures. But this scenario is an observation that is tangential to the key findings we are reporting in this study. We are trying to keep the discussion focused on the induction of aggregation in the recipient Sup35-GFP GPI cells and the point we emphasize in the Results and Discussion is that initiation of "infection" in the Sup35-GFP GPI recipient cells requires "transfer of all or part of the original co-aggregate". We have provided an explanation for this difference in the Discussion (p. 19-20) where we note that for shearing to occur within a nascent Sup35-GFP GPI aggregate, the Sup35-GFP GPI aggregate must "grow large enough to create a sufficiently frangible surface on which fracture can occur, the size apparently being dependent upon the length of time the two cells are in contact". The reviewer makes some very interesting suggestions which we would like to address in future studies but we feel are beyond the scope of this current paper which is already very long. 
It would be also interesting to determine by colocalization
.).
We agree with the reviewer that our study opens the door to many new interesting experiments. Many of this reviewer's comments appear to be based on an assumption that the GPI-anchored Sup35 aggregates are intracellular and/or that the aggregation events are an intracellular process. As we discuss in detail (please see point #15), all of our data point to the conclusion that this is incorrect. As we show clearly in Fig. 4 and Fig. 5 , we observed precisely what the reviewer expects -a dramatic increase in GFP fluorescence independent of a change in Sup35-mC GPI signal. Also, as mentioned in point #15, we observe a 100% correlation between the punctate GFP aggregates observed by microscopy and the presence of aggregates as detected by biochemical assays. We biochemically determined that the Sup35-GFP GPI cells acutely co-cultured with Sup35-mC GPI cells then purified by FACS sorting have GFP + aggregates after 6 passages (Fig. 4B) . We have now inserted an additional figure showing biochemical characterization (via Filter trap assay) of aggregate induction after acute co-culture (3 days) demonstrating the presence of detergentinsoluble GFP+ aggregates only in co-cultures of Sup35-GFP GPI (recipient) with Sup35-mC GPI (aggregate donor) cells (Fig. S7) . Fig. 4D , we show what is visualized as one large seeding entity or aggregate being subdivided into two smaller aggregates on separate cells and provide evidence that the sheared aggregates themselves have seeding activity. We argue this fulfills the widely-used definition of fragmentation. The structural characteristics of the aggregates in our study are likely to be very different from the classical amyloid fibrils that have been extensively studied in many systems. This was precisely what motivated us to undertake the studies reported in this manuscript since little consideration has been given to how tethering a protein to a membrane, as is the case for PrP, might impact how a protein aggregates. The processes we observe in this system are highly complex and difficult to quantitate but are representative of events reproducibly observed over the course of multiple independent experiments as stated in the Results. The events observed likely depend upon many factors that are beyond experimental control, confounding any meaningful attempts at quantitation. We noted that our observations were representative of events observed in the course of 6 independent experiments (p. 12). We now include additional quantitative information about the number of aggregate induction and fragmentation events observed in representative timelapse experiments (p. 13-14). We acknowledged that we did not observe TNT-like structures in association with every aggregate induction event and at this point we cannot provide an explanation for this result. We consider that cell-cell contact can be defined as occurring via intimate cell approximation or through filopodial/TNT-like structures, the latter being a special form of intercellular contact. Thus, these distinctions do not affect the major conclusion of our study that direct cell-cell contact is strongly associated with intercellular spread of GPI-anchored protein aggregation. Kanu et al (2002) while studying mouse prion. Indeed, it has been shown that cell-cell contact is necessary and more efficient for prion propagation. Furthermore in a more recent paper, Gousset et al (2009) have also shown that cell contact was necessary for the spreading of scrapie infection and they showed that TNTs could efficiently be used by GFP-PrP and PrPSc.
What the author forgot to mention is that very little of this information is new. Indeed, the authors failed to acknowledge the fact that these results agree with what was previously shown by
We strongly disagree with these statements. We do cite the work of others on this subject (e.g. Kanu et al., 2002; Paquet et al., 2007; Jeffrey et al., 2009 We apologize that the reviewer could not appreciate the new data in the paper. We show that expression of an amyloidogenic protein as a GPI-anchored protein surprisingly allowed the protein to propagate with all the characteristics of a mammalian TSE prion, including intercellular spread between unrelated living cells. We also visualize the induction, fragmentation, and intercellular spread of GPI-anchored aggregates, processes that are essential to propagation of mammalian TSE prions but have yet to be fully visualized and understood. By showing that GPI-anchoring can dramatically impact these aspects of self-propagating protein aggregation that are critical for a protein aggregate to act as an infectious agent, especially in the context of a peripheral exposure, our observations may help explain the long-standing question of why prion diseases appear to be much more transmissible versus other protein misfolding disorders. We are unclear on what specifically the reviewer would like quantified in this comment.
Fig. 5: Co-cultures of fixed Sup35mCGPI and live Sup35GFP-GPI (similar to Kanu et al. 2002) show that GPI aggregates were visible in these co-cultures (not with Sup35GFP-GPI or mC-GPI) and that after 6 passages, aggregates were barely visible.
The author conclude that these "observations established that fixed Sup35-mC-GPI aggregates efficiently induced acute but not persistent Sup35-GFP-GPI aggregation". It is difficult to understand how a few observations without any quantification can "establish" any conclusions. These data "suggest" acute aggregation but clearly some type of quantification will be necessary to validate the observations.
The reviewer has misquoted us. We did not state aggregates were "barely visible". We stated: "Over 6 passages, only rare examples of aggregate-positive Sup35-GFP GPI cells were found (unpublished data) and aggregates from such cultures were near the limit of detection." What that means specifically is that visual inspection of every single field of view of a 25 cm 2 culture flask of the cells lead to detection of at most 1 Sup35-GFP GPI aggregate in any given experiment. Quantitation of Sup35-GFP GPI aggregation in the cells was performed by way of a Filter-trap assay (see Fig. 5B ) where we found the amount of Sup35-GFP GPI aggregates present (if any) were at the limit of detection. We prefer to use the term "rare examples" to account for the limited albeit conceivable possibility of undetectable aggregates in our assays. In reality, the results were clear and absolutely distinguishable from the events occurring in co-cultures where both cells were live as in Fig. 4 . We have added this information to the Results to define what we mean by "rare examples".
They should also explain why fixation is inducing green auto-fluorescence and most importantly how they distinguish between auto-fluorescence and the specific signal coming from GFP.
It is well known that including glutaraldehyde as a fixative can cause autofluorescence. This is an unavoidable problem with this experiment. There are many publications and internet resources that explain this phenomenon. We have adjusted the figure legend to note that this is due to the use of glutaraldehyde fixative. The timelapse images clearly show that autofluorescence does not change over the course of the experiment, it co-localizes with Sup35-mC GPI -positive cells, and only when a Sup35-GFP GPI cell comes into contact with a Sup35-mC GPI aggregate is more GFP deposited. Using asterisks in our figures we provide examples of the appearance of this very diffuse autofluorescence to guide the reader through the data. We feel the intense increase in punctate GFP fluorescence associated with aggregate formation specifically seeded by cell surface Sup35-mC GPI aggregates is readily distinguished from the diffuse green autofluorescence.
These data show that the presence of GPI anchored Sup proteins, both in the donor and the recipient cells, is not sufficient to induce transfer despite de novo aggregate formation (or recruitment of SupGFPGPI see comments above). To better understand the exact role of the GPI in these processes, the authors could perform co-culture between fixed Sup GFP-GPI cells and live SupmCGPI (and maybe other combinations of the cell lines they produced) and verify if active transfer can occur in these conditions. It would be also very informative to determine if the initial seeding is required for active transfer.
We are encouraged that our studies have inspired the reviewer to think in this direction. These are interesting suggestions that are good topics for future more detailed studies but not appropriate for the current manuscript. However, the results of these ancillary experiments would not alter the interpretation of any of the major conclusions of our study. In addition, our paper is already very long, which was necessary to fully introduce and validate this novel system.
The authors do show in Fig. 5C that Sup35-GFP-GPI can be added on top of other Sup35-GFP-GPI aggregates. While this is a very interesting observation, the lack of quantification, once more, preclude the reader from determining the relevance of such events.
We are unclear precisely what the reviewer wishes to have quantitated in reference to Fig. 5C . We realized that we inadvertently neglected to note that the data presented in Fig. 5 were representative of 2 independent experiments and this has been corrected in the Fig. 5 legend. The point of this finding was to show direct visualization of the self-propagating nature of Sup35-GFP GPI aggregation. We felt the sequential rounds of interaction shown in Fig. 5C help to illustrate this point in the clearest way possible to the broad readership of EMBO Journal. However, this point was also demonstrated by the fact that individual Sup35-GFP GPI aggregates grow to a very large size with substantial areas that do not co-localize with the initial Sup35-mC GPI seed ( Fig. 5A and Fig. 5C , compare 1:30 vs. 3:00). This must result from continued assembly of Sup35-GFP GPI directly onto aggregated Sup35-GFP GPI that was originally seeded by the Sup35-mC GPI aggregate. The stable propagation of Sup35-GFP GPI aggregates for many cell passages (e.g. Fig. 3, Fig. S3 , Fig. S4 ) and the induction of Sup35-GFP GPI aggregates by Sup35-mC GPI aggregates further establish the selfpropagating activity of Sup35-GPI aggregates. Thus, this conclusion is well-supported by the data throughout our paper. We show the data in Fig. 5C as an interesting and obvious direct visualization of these events. As noted in point #19, quantitation of such complex events in a meaningful way in these types of experiments is exceptionally difficult because the factors contributing to them are very hard to control. However, we now include additional quantitative information about the number of aggregate induction events observed in representative timelapse experiments and have adjusted the description of the data in Fig. 5C in the Results section to clarify this issues raised by the reviewer's comment (p. 16).
Fig 6: Here, the authors look at the effects of removing the GPI anchor from Sup35-GFP-GPI (Sup35NM construct, which behaves similar to the anchorless PrPC described previously by Chesebro et al., 2005). After 2 days of treatment with Sup35NM-AF568, they see little evidence for GFP aggregation with the anchorless Sup35NM compared to the GPI-form.
The authors suggest that the anchor is therefore necessary for the self-propagating aggregation. Again, no quantification was available. Once again to separate spreading from capability to induce aggregation, the authors should try to transfect aggregate positive SupCGPI cell with SupGFP and look at aggregation of SupGFP. The GPI could be important for the active transfer of seeding aggregates to recipient cells but not for induction of aggregation itself.
It is unclear what the reviewer wishes to have quantified in this case. We have shown that no detergent-insoluble aggregates are propagated by cells expressing GPI-anchorless Sup35NM when treated with recombinant Sup35 fibrils (Fig. 6) . We have illustrated the reproducibility of this finding by showing 3 replicate wells from 1 of 2 independently performed experiments and assays for aggregates in cells and in the culture supernatant (Fig. 6B-D) . Fig. S8 illustrates that Sup35-GFP can serve as a substrate for aggregate formation as it forms aggregates when seeded with recombinant fibrils. As an additional line of evidence to fully confirm the negative infection data using rSup35NM fibrils, we have added data showing that acute co-culture of aggregate-positive Sup35-mC GPI cells with Sup35-GFP cells does not induce detectable Sup35-GFP aggregates (Fig.  S7) . We feel that the reviewer's comments are inaccurate in this instance. We are not sure how the reviewer arrived at this opinion. We are not using the data from the 10x objective to support any of the detailed cellular mechanistic data that we have described in this paper. Quantitation was performed using images acquired with a 10x objective. We also acquired images at 40x magnification, but there is less information in these images (i.e. fewer cells/field of view). We feel our images with the 10x objective are perfectly acceptable for illustrating the presence of the very prominent punctate GFP aggregates, which is the intended purpose of these images. We have provided representative 40x images in the revised manuscript.
Throughout the paper, the pictures acquired by
Live imaging: what is the rationale for performing live imaging of single cells by taking frames every 25 or 45 min? It is clear that they are missing many events...
The events we are imaging are unpredictable, very hard to manipulate experimentally, and appear to occur on these time scales. We wish we could force the cells to interact on cue but this is as yet beyond our capabilities. We argue that the assertion we are "missing many events" is an assumption on the part of the reviewer. The timelapse experiments require observation over the course of at least one day. Higher sampling rates can lead to phototoxicity/death of the cells being observed over such a long time course and compromise the interpretation of the data. In each experiment we acquire images (full Z-stacks) from as many as 23 different fields of view, which places limits on the time intervals that can be used. We have added information to the "Fluorescence microscopy and image processing" section of the Supplementary Materials and methods to explain these considerations. I sent it back to referees 1 and 3: despite his/her negative assessment, referee 3 specifically asked to see the revised version of the manuscript. I also asked referee 1 to comment on your responses to referee 3. As you will see, referee 1 now fully supports publication of the manuscript in its current form. Referee 3, while recognising that you have addressed some of his/her comments and that the manuscript has improved, is still negative. However, given the positive assessment of referee 1 (and referee 2 in the first round), and since we already over-ruled referee 3 in the initial review, we will be able to accept your manuscript for publication in the EMBO Journal. However, referee 3 does provide a long review of the revised manuscript, and some of his/her suggestions (in terms of text changes) may be useful. I would also like you to respond to the criticisms raised. I would therefore ask you to prepare a point-by-point response to this report, and to incorporate any suggested changes that you feel would improve the clarity of the text into a revised version of the manuscript. Please could you then send both documents (the point-by-point response and the final manuscript text) by e-mail, which we can then into the system. Once we have this final version and I have had the chance to look through it, we should be able to accept your manuscript for publication in the EMBO Journal.
I look forward to receiving your final revision.
Yours sincerely, Editor EMBO Journal REFEREE REPORTS Referee 1 comments:
The authors have made considerable revisions to both the text and figures of their manuscript on GPI anchoring and its role in horizontal spread of prions. These revisions fully addressed my original rather minor criticisms.
In addition to my criticisms, considerably more substantial concerns were raised by another referee of this paper. I have also had an opportunity to consider these criticisms and the authors' revisions in response. In a broad sense, the criticisms related to two aspects of the study involving its novelty/impact, and its technical quality.
Regarding the novelty, the major criticism was that recent work from Krammer et al was largely similar but not really discussed by the authors of the present work. I found this criticism to be only partially valid and the authors' reply thorough and complete. The main difference between the two studies is that the earlier study transplanted a yeast prion into the cytoplasm of mammalian cells; thus, a cytosolic phenomenon in yeast was now studied in the cytoplasm of a distant organism, which led to some very interesting conclusions regarding cytosolic requirements. This did not specifically relate to horizontal spread, as the cytosolic reconstituted prion in the mammalian cells was transmissible vertically (i.e., upon cell division). The new study is superficially similar in also using a similar strategy of transplanting Sup35 from yeast to mammals. The novelty comes in moving it now to the cell surface (totally different compartment from many points of view), studying whether membrane anchoring is an important facet, and most importantly, studying horizontal cell-to-cell spread as opposed to vertical spread.
The new study establishes a very nice simplified model system to study horizontal spread of protein aggregation that generates some new insights and should prove useful for further studies. I found the study analogous in many ways to a classic paper in which the essential features of SNAREs were studied by putting them on the cell surface and using cell fusion assays to analyze their functions (Hu et al., Science, 2003 , from J. Rothman's lab).
The second issue of technical quality was, I feel, also completely addressed. The criticisms were largely valid, although not all of them were of critical importance to the ultimate conclusions.
Given the thorough responses by the authors, and in my view, the novelty of the conclusions and system, I support its publication.
Referee 3 comments:
Reviewer #3
I would like to thank the authors for their effort to answer our original concerns. I also appreciate the addition of some data (new images or addition to the text throughout) which make this version of the manuscript much clearer. However there are still a number of issues that need to be addressed. Indeed despite their efforts it appears that the authors have not fully understood some of the relevant points I have raised and therefore I will try to make myself more clear in this reply in the hope that my comments will be fully appreciated. I have two major concerns. One is the novelty of the manuscript and the second is that the data shown do not fully support the conclusions.
Abstract:
Line 27: It is not demonstrated that formation of prion like aggregates of Sup 35 is GPIanchor dependent. Krammer et al clearly showed that the replication of Sup35NM can occur in the cytosol of N2a cells exposed to the same recombinant fibrils that they use, independently of the presence of the GPI anchor. Furthermore, although the authors have added a few statements in the paper conceding that membrane anchorage per se and not just the GPI moiety may be responsible for the observed phenomenon, the influence of membrane anchorage per se as opposed to membrane anchorage specifically via a GPI linkage on the transmissibility and/or misfolding of a protein remains a biologically relevant question. Certainly, the authors results show that GPI anchorage is sufficient for enhancing cell-cell transmission; but it must be noted that it has not been demonstrated that it is necessary. The relevant controls to distinguish between these two possibilities have not been done.
For the same reason, line 32 is misleading (eg, they do not show that the GPI anchor facilitates the propagation)
Introduction: Line 86. Although they concede one line to the work of Gousset they just mention spreading of PrPSc, while these authors have also shown spreading of infection by this means. Therefore this paper should be discussed in the subsequent lines (lines 90 to 103) when they talk about infection spreading. And when they talk about neuroinvasion and involvement of the immune system, as this paper (and a subsequent review, Gousset and Zurzolo 2009) proposes TNTs as a mechanism for spreading from the pheriphery to the CNS through the involvement of DC cells.
Line105. Also in this case the choice of wording is not so precise and appropriate as they state in their rebuttal letter. Indeed they cannot say that GPI mediated the "induction" of protein aggregation since the GPI anchor is dispensable (Krammer et al) as they know. So this line is again misleading for the EMBO J readers.
Line126-129. Here they only cite the Krammer paper in the context of vertical transmission of the aggregate. Therefore the uninitiated reader does not understand that it has been shown before that the yeast sup35 is able to replicate "like a prion" in the cytosol of N2a cells upon induction by exposure of the cells to recombinant NM fibrils (eg, the same experiment that they perform here with the sole exception that their version of Sup35NM is GPI anchored). Furthermore, since this data is present in the literature it should be discussed and compared with their own results, especially if they want to assess any relevance of the GPI anchor in the prion-like replication process of SupNM in mammalian cells.
Line 132. Using this new model.... this is also misleading for the reader, which new model? The experiment has been done already, the only difference is in the type of constructs they use (eg, cytosolic in the Krammer case, GPI anchored in their own case) but the settings are exactly the same and the outcome as well (as concerns aggregate replication). In both cases prion-like replication of SupNM is induced when this protein is present (either as cytosolic protein or as GPI-anchored one) in the cells exposed to the fibrils.
Results. Lines 148-151. Referring to the lower part of Fig 1B it is clear that a large amount of GFP does not colocalize with antiSup NM antibody, suggesting that a lot of GFP gets cut from the NM domain. As I stated bifore, this should be seriously considered and commented in the manuscript as it could affect the following experiments of aggregate splitting and replication.
Lines 152 on. Here when they talk of their method to prepare recombinant fibrils and the following experiment of challanging N2a cells with these for 48 hours they should state : as previously shown by Krammer and colleagues. Indeed the experiment they perform here with the GPI version of Sup35NM version is exactly the same as performed by Krammer et al. with the cytosolic version of the protein. Do the authors believe that the Krammer results are absolutely irrelevant for their own? In my opinion they should discuss the fact that Krammer et al. show prion-like replication induced by recombinant fibrils in the presence of cytosolic Sup35NM without the need of a surface Sup35NM. Here they suggest that the fibrils exert their effect by binding to the surface GPI anchored Sup35NM. Because Krammer has shown that fibrils induced sup35NM replication in the absence of surface Sup35NM I believe that it is important that they discuss at this point of the paper the differences between their results and these previous data.
Lines 169 -204 . The experiments described here in Fig 3 ( eg, to confirm replication, exclude residual fibrils etc) have previously been performed in the paper of Krammer and both papers come to a similar conclusion: that aggregates are infectious and replicate (either in the presence of a cytosolic sup35 or a GPI anchored one). However, also in this case there is no mention or discussion of the Krammer data.
Up to this point the only novelty of the paper is that a GPI-anchored version of Sup35NM can be induced to self replicate following fibril addition to N2a cells expressing this protein in a manner that appears to be very similar to what has been recently described for a cytosolic construct (W/0 GPI anchor). However in my opinion, the way they present the data (omitting citation/discussion of previous literature) is misleading to the reader unfamiliar with the subject to whom it may appear that this is the first time this has been shown and that the GPI anchor is essential.
From this point on the paper should be novel and examine the role of GPI in the spreading of aggregates and provide evidence about the mechanism. However: Line 207 -212. The authors state here that they can "often visualize (the aggregates) as cell surface sheet-like accumulations". This leads us back to an issue that we brought up earlier. While the new figure S4 is showing some cell surface aggregation more convincingly, the lack of high-resolution imaging prevents the reader from appreciating the data fully (eg,, the specific sheets-like characteristic of the aggregates).
Line 217-231. The use here of mcherry which, as the authors admit, can facilitate the spontaneous nucleation of associated Sup35 is not justified since it could create artefactual results. Indeed, aggregates do not occur spontaneously in culture of N2a cells transfected with Sup35GFPGPI, but only after exposure of these cells to fibrils or in coculture with cells expressing self aggregating Sup35mCherry GPI. Therefore it would be more convincing if the co-culture experiments were performed with another fluorophore-linked Sup35GPI protein that does not spontaneously aggregate (perhaps one of the many GFP spectrum variants), but does display the same morphology as Sup35-GFPGPI puncta when 1) exposed to Sup35 fibrils and 2) co-cultured with persistently propagating Sup35-GFPGPI cells (induced to propagate aggregates using the accepted method of exposing them to Sup35 fibrils) and vice versa.
Lines 243-245. This phrase does not make much sense. Indeed, being Sup35mC cytosolic and in a non aggregated state, as they themselves state (line 223), why should one expect the appearance of Sup35GFPGPI aggregation in coculture conditions? Instead they should repeat the co-culture experiment using N2a cells expressing soluble Sup35 in aggregating state after being exposed to fibrils (as in the paper from Krammer and colleagues). I consider both the experiments suggested here to be essential to understand what is going on in their culture, including showing the relevance of the GPI anchor for the transfer of the aggregates.
Lines 255 on. Referring to videos 1 and 2 it is far from clear that the authors conclusions are supported by the low time-resolution studies provided in the videos. One can observe fluorescent material and cells shifting positions from frame to frame. Even if one takes this material for larger aggregates being subdivided, or clusters of aggregates being separated, and adhering to different cells it is far from clear that the steps of shearing, seeding and amplification of this material is taking place. On line 265 they state...."these events generated at least two new independent particles capable of interacting with other cells to initiate new seeding events. In a typical experiment we may observe at least 4 aggregate shearing events". What does this mean? That they can follow the same aggregate going through 4 different shearing events? Why they do not show these events in more and better quality movies?
Line 290. If, in a typical experiment they observe 17 aggregate formation events they should be able to produce more convincing movies.
Line 293. Even if one was able to see in their one example all the steps of Sup35 aggregate transfer, shearing, induction of new aggregates, etc, it is not clear to me here how they could state that these experiments "visualise" self propagation and spreading of PrPSc. Although they convincingly Line 345 on. As we have previously stated the use of a membrane-bound (not GPI anchored) negative control is necessary to specifically determine the role of the GPI-anchor during this process. The lack of such a control renders the conclusion that "GPI-anchoring" plays a critical role in transfer not valid. If the authors do not add this control, they can only conclude that plasmamembrane anchoring is necessary, but they can't really say what type of anchoring (eg, GPI, TM etc...) is important.
Discussion. Line 392 on. They misquote the Krammer paper which does not support the existence of orthologs of HSP104 but suggest "an independent mechanism......" Furthermore it is not clear what is their evidence suggesting that "GPI anchoring of Sup35NM compensated for the absence of these chaperones"..... Although the discussion has been shortened it is still too long and focused on the role of the GPI anchor in prion spreading, which is too far fetched from what the authors are showing here.
Minor comments
Line 147 figure not cited after describing the result.
Could show imaging data of Figure S7 . We regret that the reviewer does not appreciate the control for this experiment that is shown in this paper. We do provide a control, GPI-anchorless Sup35, which is identical to the GPI-anchored version in every way with the exception of lacking the GPI anchor. Importantly, this includes trafficking of the protein through the secretory pathway (i.e. ER, Golgi) before ultimately being secreted from the cells to the extracellular milieu, the compartment where we have shown very clearly aggregate formation is induced for cells producing GPI-anchored Sup35. Thus, the GPIanchorless Sup35 used in our studies is in fact an appropriate control for comparison with Sup35-GPI. We share the reviewer's enthusiasm to explore the contributions of other forms of membrane association, but we strongly feel it is unnecessary and inappropriate for this manuscript. As requested by the reviewers, in the revised manuscript we drew more attention to the possibility that other forms of membrane association may also produce the same effect. But consider the fact that there are many other types of membrane association. Also consider the ramifications of a negative result for a given construct, which would require extensive control experiments to establish that the lack of prion behavior is not due to an artifact associated with that particular construct. There is simply insufficient space in the current manuscript to fully introduce, characterize, and test all such conceivable constructs. Moreover, regardless of the findings it would in no way alter our conclusion that GPI-anchoring facilitates the propagation and spread of Sup35 aggregation in our system. Obviously, our findings raise the question of whether other forms of membrane association might behave in this system, and we are working on this project. We hope that the results will be wellreceived given the keen interest in these experiments. (and a subsequent review, Gousset and Zurzolo 2009) 
2) Introduction
proposes TNTs as a mechanism for spreading from the pheriphery to the CNS through the involvement of DC cells.
A reference to address all of these issues was added (lines 104-106).
3) Line105: Also in this case the choice of wording is not so precise and appropriate as they state in their rebuttal letter. Indeed they cannot say that GPI mediated the "induction" of protein aggregation since the GPI anchor is dispensable (Krammer et al) as they know. So this line is again misleading for the EMBO J readers.
We feel the reviewer is taking the topic sentence for this paragraph out of context. If you read the following sentence you will see that we proceed to explain what specific form of membrane anchoring we tested, why, and an acknowledgement that other forms of membrane anchoring could have a similar effect. We also revisit this subject again in the Discussion. Hence, we do not feel this is misleading for the readers. Unfortunately, the reviewer has overlooked a key control in this experiment: the results of immunolabeling Sup35-GFP GPI cells with anti-GFP (Fig. 1B) . The relative amount and sub-cellular localization of anti-GFP labeling that did not co-localize with GFP fluorescence was similar, suggesting that this simply represents a population of GFP-tagged molecules that were not immunolabeled. We made note of this point when we described the data in Fig. 1B . This is an often-overlooked technical problem associated with immunofluorescence experiments, balancing fixation conditions that accurately preserve antibody reactivity, organelles and molecular distribution with conditions that allow for complete labeling and access of antibodies to all intracellular compartments. We used a polyclonal anti-GFP antibody to attempt to minimize the chance for fixation-induced loss of reactivity. If the reviewer's interpretation were correct, we should see abundant Sup35NM fragments on our immunoblots of the Sup35NM-GFP GPI cells when blotted with anti-Sup35 antibodies and there is no evidence that this is the case (Fig. 3B) . Likewise, the detergent insolubility data also establish that Sup35-GFP GPI aggregates consist of full-length Sup35-GFP GPI molecules (Fig. 3B) . Our experience over the course of several years has suggested that one must be careful about conclusions based on consideration of immunofluorescence data alone. Please see our responses to comments #1 and 4 and comments of reviewer #1. Also please note that the technical concept of using fluorescent protein aggregates to study the prion infection process was first published by our laboratory years ago (Magalhaes et al., J. Neurosci., 2005) where we also proposed that TNTs may participate in the intercellular spread of PrP Sc . Fig 3 (eg, to confirm figure S4 is showing some cell surface aggregation more convincingly, the lack of high-resolution imaging prevents the reader from appreciating the data fully (eg,, the specific sheets-like characteristic of the aggregates).
7) Lines
8) Lines 169 -204. The experiments described here in
This seems to be an issue of semantics. We chose the term sheet-like accumulation because in our eyes it most accurately described what we observed -clustering of fluorescence over a large apparently continuous region of the cell surface. It reminds us of antibody-induced "capping", but we do not wish to use this word due to its association with an antibody-induced process. We think the sheet-like features are depicted in the paper both through presentation of our images as a single Z-slice through such sheets (Fig. 4A and Fig. S4 ) and 3D-projection images as in Video 2 where the reader can view an aggregate from many angles. The reviewer comments on the resolution of the images, but we can assure you there is little improvement from imaging such structures on a highend Zeiss point-scanning laser confocal, the highest resolution system available to us. The images shown are representative of the highest resolution we can achieve at the level of light microscopy. We do not have access to any of the very new sub-resolution fluorescent imaging systems that break the "diffraction limit" so our data represent the best that we (and most labs around the world) would be capable of providing. Our previous rebuttal letter and revised manuscript have addressed this issue. Yes, mCherry can aggregate spontaneously under certain circumstances. However, careful scans of the literature and discussions with scientists actually using fluorescent proteins in assays highly sensitive for protein aggregation will verify that this can happen with virtually all fluorescent proteins. We have established that aggregation of mCherry-tagged proteins in our system is dependent on the presence of the Sup35NM domain. We explain in the manuscript that we selected for cell lines expressing high levels of mCherry-tagged Sup35-GPI. It is well known that yeast cells spontaneously convert from the prion-negative to prion-positive state at a very low rate and that this rate is dramatically enhanced by overexpression of the cognate prion protein. This is actually one criteria used to prove a protein is a prion in yeast (Wickner, Science, 1994) . Hence, it may be either the properties inherent to membrane-associated mCherry, a consequence of Sup35-mCherry GPI overexpression, or both that contribute to the aggregation observed in these cells. However, this by no means precludes its use in our experiments. We established through many lines of evidence that Sup35-mCherry GPI aggregates are indistinguishable from Sup35-GFP GPI aggregates whether the latter are induced by co-culture or treatment with rSup35NM fibrils. Consequently, there is little benefit to be gained by repeating all our experiments with a different fluorescent protein. The reviewer's comments suggest that perhaps they do not understand the Sup35-mC construct. Sup35-mC is not localized to the cytosol as in Krammer et al. On the contrary, as we stated above, it is exactly the same as the GPI-anchored version except it lacks the GPI anchor. It has a signal peptide (labeled in Fig. 1A ) that directs its export through the secretory pathway and is ultimately secreted from the cells. We noted this in the manuscript. Evidence for secretion is provided in Fig.  S5 where in fact we carefully quantitated the amount of mCherry-tagged protein released to the culture media from Sup35-mC GPI cells vs. Sup35-mC cells. This should clarify our point in lines 243-245. This control helps to address the concerns this reviewer had about using mCherry-tagged Sup35 by showing that exposure of Sup35-GFP GPI cells to very high levels of non-aggregated, mCherry-tagged Sup35 (in an anchorless form) fails to induce aggregation of Sup35-GFP GPI . Perhaps this unfortunate misunderstanding is partially to blame for many of this reviewer's concerns about comparing our data with that of Krammer et al. where they expressed a Sup35NM domaintagged protein exclusively in the cytosol. We have carefully examined the manuscript and cannot see how it could be modified to present this information more clearly than in its current form. We regret that the reviewer does not appreciate the sequence of events presented in these videos. Yes, the cells move between frames but we can unequivocally identify the cells in each frame at the time resolution used for these experiments using both the fluorescence and DIC images. We fail to understand why the reviewer is not convinced that shearing, seeding, and amplification is taking place. The initial frames begin with a large co-aggregate shared between two cells for 2:20 hours prior to the first image shown in Fig. 4D (see Video 1 for frames of earlier time points). The large co-aggregate is split into two smaller aggregates clearly localized on each of the two cells in question. Finally, a massive aggregation of Sup35-GFP GPI as visualized by the increase in size and intensity of GFP fluorescence (in this case visualized as bright white due to co-localization with very bright mCherry-tagged aggregate) occurs very shortly after interaction of the Sup35-GFP GPI cell with the newly-sheared, cell surface Sup35-mC GPI aggregate. We are somewhat confused by these comments as having presented this data now at many conferences and forums this is the first time we have encountered an individual who has been unable to appreciate these events.
11) Line
12) Lines
13) Lines
Regarding the "4 aggregate shearing events comment", we were stating that we typically visualize at least 4 independent aggregate shearing events (different cells, different fields of view) per Please see response to comment #1. We will have to again agree to disagree on this point. At no place in this manuscript do we state that GPI-anchoring is the sole mode of membrane anchoring that can facilitate propagation of protein aggregates. We clearly show that it can work and that is a message emphasized throughout the manuscript. We are not quoting the Krammer et al. paper on Line 392. We are stating our legitimate interpretation of their findings. As we cite in the Introduction, Doyle and Wickner (2009) note that there are mammalian intracellular proteins in the same family as Hsp104. Hence, this raises the possibility that an as-yet-undiscovered Hsp104-like activity may be present in the mammalian cytosol. We have adjusted the location of the reference to Krammer et al. to avoid implying we are quoting their paper and inserted a reference to Doyle and Wickner (2009) to clarify this issue.
Discussion
Regarding the subject of "GPI-anchoring compensating for the absence of chaperones", we devoted several lines of text in the Introduction and Discussion to explain the rationale for this conclusion. Propagation of Sup35 prions in yeast requires precisely tuned levels of the cytosolic chaperone protein Hsp104. We noted that mammalian cells lack chaperones with the specific aggregatefragmentation activity of Hsp104 that is necessary to amplify seeding-competent particles. We acknowledged that the data of Krammer et al. might suggest the possibility that a mammalian ortholog with this activity may exist in the mammalian cytosol, but also cited literature indicating there is no evidence for the existence of chaperones with this critical aggregate fragmentation activity present in the extracellular environment of mammalian cells. Therefore, by expressing Sup35 as a GPI-anchored protein localized to the mammalian cell surface/extracellular environment in our study, propagation of Sup35-GPI aggregates would be attributed to GPI-anchoring dependent compensation for the absence of this essential chaperone activity. We have examined the relevant text in these sections and cannot determine how it could be restated to more clearly present this information.
In the revised manuscript we shortened the Discussion considerably per the reviewer's request. We cannot shorten the Discussion any further.
Minor comments 20) Line 147 figure not cited after describing the result.
In creating the revised version, this reference was accidentally deleted. Thank you for catching this error. Figure S7 .
21) Could show imaging data of
We do not feel this is necessary to prove the main conclusion of this experiment.
22) Figure S4 the plasma membrane localization of the aggregates in chronically "infected" cells does not correspond to the expected intracellular localization of different strains of prions in a variety of different cell lines including N2a cells, suggesting that the authors should not extend their results obtained using yeast prions to mammalian prions (see abstract and discussion).
The reviewer may find it interesting to carefully review the literature on this subject. It receives little attention but there is cell-surface PrP Sc present in chronically-infected N2a cells. This was formally demonstrated by the Prusiner lab to name one example (e.g. Vey et al., PNAS, 1996) .
